Director of Business Analytics & Forecasting Company Background Eagle is a specialty pharmaceutical company working to advance safe and efficient injectable treatments for patients across oncology, critical care, and orphan diseases. As a group of inventors, visionaries, and life science leaders, we are bound by the belief that patients deserve the best possible experiences in healthcare. That s why our focus on engineering new formulations is designed to make life-saving medicines easier to use. We discover and develop new formulations to make medicines more convenient and faster to use. We look to unlock the potential in proven medicines to benefit more patients and healthcare providers. Our goal is to provide safe and accessible products through the application of innovative formulation technology to FDA-approved medicines, as well as through the discovery and development of novel therapeutic agents. Our Competitive Strengths Eagle Products Pushing healthcare forward requires us to propel medicines to their full potential. We make possible what others consider impossible. Our product portfolio includes: BENDEKA (bendamustine hydrochloride) Injection RYANODEX (dantrolene sodium) for injectable suspension Pemfexy (pemetrexed injection) tentative approval by FDA Pipeline We analyze the unmet needs of patients continuously looking for ways to further improve therapies for those who need them. To help realize this goal, our teams have been hard at work to grow our portfolio of oncology, critical care, and orphan disease treatments through the development of biologics and small molecules. Our pipeline includes, but is not limited to: Ryanodex Exertional Heat Stroke Nerve-Agent Induced Brain Damage Acute Radiation Syndrome Fulvestrant Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer, Who Have Gone Through Menopause and Have Not Been Previously Treated with Endocrine Therapy HR-Positive Advanced Breast Cancer, Who Have Gone Through Menopause and Whose Disease Has Progressed After Endocrine Therapy HR-Positive, HER2-Negative Advanced Breast Cancer or Breast Cancer That Has Spread to Other Parts Of The Body (Metastatic), in Combination With Palbociclib or Abemaciclib in Women Whose Disease Has Progressed After Endocrine Therapy Striving to Improve Patient Care Eagle Pharmaceuticals is committed to developing and commercializing proprietary innovations that are intended to optimize safety, efficiency and accessibility for patients and healthcare professionals. We believe that our products developed for the oncology, orphan diseases, and critical care therapeutic areas will provide patient benefits relative to current products, such as: Improving patient experiences Enhancing treatment safety Reducing dosing errors Reducing drug volume and infusion times Speeding up or eliminating drug reconstitution Eagle Pharmaceuticals is currently seeking a highly qualified Director of Business Analytics & Forecasting to support our commercial organization decision-making through commercial analytics processes, delivering analytical and strategic insights into new product launch activities, product label expansion programs, new product development project selection and management and product acquisition opportunities. This individual will actively participate with commercial and financial planning efforts by providing objective in-depth analyses on current and future specialty markets; establish product forecast models; lead periodic revenue planning and forecasting activities; establish key metrics and track performance product launches; develop customer insights and competitor assessments. This individual will also analyze data to identify and define critical business issues and opportunities for growth, collaborate with external consultants and internal teams to build a strong understanding of the external markets the company operates in and may enter with new product offerings. Responsibilities: Proactively and continuously assess the relevant marketplaces and dynamics, customers and competitors to enable strategic decision-making regarding products and business operations. Create, manage, validate, and refine revenue forecasts in collaboration with Commercial and Finance leads. Develop and implement market research plans in all customer segments, including providers, payers, patients, caregivers, etc., in collaboration with cross-functional teams to support pre-launch and launch activities for lead and future indications. Collaborating with IT to build business intelligence infrastructure. Partner within appropriate cross-functional teams by providing strategic insights as well as in-depth product and marketplace knowledge to inform strategic decisions. Support the New Product Discovery team in assessment of new products and expansion indications. Provide analytical support to Corporate Development during due diligence for in-license opportunities and partnering activities. Continuously monitor public and private competitors and keep abreast of clinical, regulatory, commercial, and financial developments and their impact on the company. Contribute to cross-functional or other project teams, helping the overall business evolve, improve & excel. Deliver results in a timely manner with high levels of accuracy and objectivity Strive to exceed expectations and evolve processes Ensures compliance with corporate policies and procedures, as well as, US healthcare laws and regulations. Education, Experience, Knowledge and Skills: 7 years in specialty pharmaceutical companies or related experience in commercial related roles with at least 3 years in a commercial analytics leadership role. Previous experience in oncology highly desirable Bachelor s degree required. MBA or other related graduate-level degree preferred. Previous experience with leading teams, managing and developing high performingindividuals. Extensive experience with the following: Proven ability to interact and communicate effectively with C-suite executives on a regular basis Proven track record for leadership, collaboration, teamwork and consistently exceeding qualitative and quantitative targets and goals. Development of excel based revenue forecast models. Leading and managing qualitative and quantitative primary market research with all segments of the healthcare system. Extensive experience in use and analysis of secondary data sources (e.g., IMS, IQVIA, Symphony Health Solutions, etc.). Building systems for tracking and evaluating market and competitive landscape. Evaluating and assessing development options as it relates to commercial potential Product launches within branded specialty markets Strong Excel analytical skills including: statistical analysis, pivot tables, and financial forecasting functions Work Conditions: 5% Travel All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status. If interested, please apply at: Associated topics: analyze, business analytic, consult, financial analytic, financial reporting analyst, forecasting, guidance, law, market, monitor Associated topics: analyze, business, business analytic, business finance, business intelligence, financial analytic, financial reporting analyst, investment analyst, law, strategy
* The salary listed in the header is an estimate based on salary data for similar jobs in the same area. Salary or compensation data found in the job description is accurate.